The bronchodilator effects of the novel anti-inflammatory compound TPI 1020, alone and in combination with formoterol, in conscious guinea pigs Source: Annual Congress 2009 - Preclinical models in drug development Year: 2009
A novel TRPA1 antagonist inhibits ovalbumin-induced bronchoconstriction in guinea pig models Source: International Congress 2019 – Airway inflammation: pharmacological mechanisms and novel targets Year: 2019
Effect of SMP-028, a novel anti-inflammatory agent, on experimental allergic asthma in guinea pig model Source: Annual Congress 2010 - Regulation of airway pharmacology Year: 2010
Alpha-1L, but not alpha-1H, adrenoceptor antagonist prevents allergic bronchoconstriction in guinea pigs in vivo Source: Eur Respir J 2001; 18: Suppl. 33, 104s Year: 2001
Selective PDE inhibitors in modulation of cough reflex and bronchoconstriction in healthy and ovalbumin-sensitized guinea pigs Source: Annual Congress 2010 - Models of airways disease Year: 2010
Late asthmatic response is modulated by TRPA1 antagonists in ovalbumin-induced bronchoconstriction in anaesthetized guinea pigs Source: Annual Congress 2012 - New drug targets and pre-clinical models for respiratory diseases Year: 2012
AWD 12-281, a new PDE4-inhibitor, suppresses allergen-induced [DCquote]early phase“ bronchoconstriction in sensitized guinea pigs Source: Eur Respir J 2003; 22: Suppl. 45, 107s Year: 2003
Compound X – an inhaled β2 agonist with equivalent potency and superior duration of action (DOA)/ therapeutic index (TI) to salmeterol in the anaesthetised dog model of bronchoconstriction Source: Annual Congress 2008 - Novel treatments for respiratory disease Year: 2008
Changes of chemically induced cough and specific airway resistance during capsaicin nasal challenge in awake guinea pigs Source: Eur Respir J 2001; 18: Suppl. 33, 85s Year: 2001
Prevention of induced bronchoconstriction in sensitized guinea pigs: efficacy of common prophylactic drugs Source: Eur Respir J 2003; 22: Suppl. 45, 99s Year: 2003
The effects of repeated nasal allergen challenge on cough response in sensitized guinea pigs Source: Eur Respir J 2003; 22: Suppl. 45, 475s Year: 2003
A novel dual-agonist challenge model in guinea pigs for assessment of individual and combined muscarinics antagonists and b2 adrenoceptor agonists bronchodilator efficacy Source: Annual Congress 2011 - Models of disease and drug actions Year: 2011
Pathogenic effect of intratracheal exposure on nanocarbons - in vivo study on guinea pig model Source: Eur Respir J 2004; 24: Suppl. 48, 606s Year: 2004
Effect of chronic ovalbumin sensitization on bronchoconstriction induced by hyperventilation in guinea pigs Source: Eur Respir J 2001; 18: Suppl. 33, 103s Year: 2001
Discovery of competitive thromboxane receptor (TP) antagonism by diclofenac in guinea pig airway and vascular tissues Source: Annual Congress 2007 - Recent advances in airway smooth muscle biology Year: 2007
Alternative method to profile slow onset bronchodilators in guinea pig trachea in vitro for potency and pKB analysis Source: Eur Respir J 2004; 24: Suppl. 48, 127s Year: 2004
Antagonism by reproterol of adenosine-mediated tension responses in isolated guinea pig trachea Source: Eur Respir J 2003; 22: Suppl. 45, 106s Year: 2003
The benefit of new antileukotriene derivatives on airway responsiveness in ovalbumin-sensitized rats Source: Eur Respir J 2004; 24: Suppl. 48, 219s Year: 2004
The inhaled anticholinergic agent, aclidinium bromide, reverses cholinergic-induced bronchoconstriction in guinea pigs with a fast onset of action and a long duration of effect Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD Year: 2008
Assessment of the potency and duration of action of aclidinium bromide in guinea pig isolated trachea in vitro Source: Annual Congress 2007 - Recent advances in our understanding of the mechanisms of asthma treatment Year: 2007